The overexpression of Parkin was indeed able to significantly reduce ROS levels, as measured by ESR, both in the CS3BE cells and in primary fibroblasts from CS-A patients (Figure 6A, 6B), indicating that the source of ROS in CS-A cells is the dysfunctional mitochondria. The gene discussed is PRKN; the disease is chromosome-type aberration frequency.